Gene Review:
SPINT2 - serine peptidase inhibitor, Kunitz type, 2
Homo sapiens
Synonyms:
DIAR3, HAI-2, HAI2, Hepatocyte growth factor activator inhibitor type 2, KOP, ...
- Tumor suppressor activity and epigenetic inactivation of hepatocyte growth factor activator inhibitor type 2/SPINT2 in papillary and clear cell renal cell carcinoma. Morris, M.R., Gentle, D., Abdulrahman, M., Maina, E.N., Gupta, K., Banks, R.E., Wiesener, M.S., Kishida, T., Yao, M., Teh, B., Latif, F., Maher, E.R. Cancer Res. (2005)
- The hepatocyte growth factor regulatory factors in human breast cancer. Parr, C., Watkins, G., Mansel, R.E., Jiang, W.G. Clin. Cancer Res. (2004)
- Hepatocyte growth factor activation inhibitors (HAI-1 and HAI-2) regulate HGF-induced invasion of human breast cancer cells. Parr, C., Jiang, W.G. Int. J. Cancer (2006)
- Serum hepatocyte growth factor activator inhibitor type I (HAI-I) and type 2 (HAI-2) in prostate cancer. Nagakawa, O., Yamagishi, T., Akashi, T., Nagaike, K., Fuse, H. Prostate (2006)
- Differential expression of bikunin (HAI-2/PB), a proposed mediator of glioma invasion, by demethylation treatment. Schuster, J.M., Longo, M., Nelson, P.S. J. Neurooncol. (2003)
- Sparrows discriminate between diets differing in valine or lysine concentrations. Murphy, M.E., King, J.R. Physiol. Behav. (1989)
- Purification and cloning of hepatocyte growth factor activator inhibitor type 2, a Kunitz-type serine protease inhibitor. Kawaguchi, T., Qin, L., Shimomura, T., Kondo, J., Matsumoto, K., Denda, K., Kitamura, N. J. Biol. Chem. (1997)
- Roles of hepatocyte growth factor activator (HGFA) and its inhibitor HAI-1 in the regeneration of injured gastrointestinal mucosa. Itoh, H., Kataoka, H. J. Gastroenterol. (2002)
- Identification and investigation of methylated genes in hepatoma. Chiba, T., Yokosuka, O., Fukai, K., Hirasawa, Y., Tada, M., Mikata, R., Imazeki, F., Taniguchi, H., Iwama, A., Miyazaki, M., Ochiai, T., Saisho, H. Eur. J. Cancer (2005)
- Purification and characterization of protein PB of betaine reductase and its relationship to the corresponding proteins glycine reductase and sarcosine reductase from Eubacterium acidaminophilum. Meyer, M., Granderath, K., Andreesen, J.R. Eur. J. Biochem. (1995)
- Therapeutic effect of (E)-5-(2-bromovinyl)-2'-deoxyuridine, caffeic acid oxidation product, and trisodiumphosphonoformate on cutaneous herpes simplex virus type 1 infection in guinea pigs. Helbig, B., Sauerbrei, A., Klöcking, R., Wutzler, P., Wicht, N., Wiedemann, U., Herrmann, G. J. Med. Virol. (1987)
- Prevention of nosocomial pneumonia using topical and parenteral antimicrobial agents. Johanson, W.G., Seidenfeld, J.J., de los Santos, R., Coalson, J.J., Gomez, P. Am. Rev. Respir. Dis. (1988)
- Genomic structure and chromosomal localization of the human hepatocyte growth factor activator inhibitor type 1 and 2 genes. Itoh, H., Yamauchi, M., Kataoka, H., Hamasuna, R., Kitamura, N., Koono, M. Eur. J. Biochem. (2000)
- Expression of hepatocyte growth factor activator inhibitor type 2 (HAI-2) in human testis: identification of a distinct transcription start site for the HAI-2 gene in testis. Yamauchi, M., Itoh, H., Naganuma, S., Koono, M., Hasui, Y., Osada, Y., Kataoka, H. Biol. Chem. (2002)
- Defect of pro-hepatocyte growth factor activation by fibroblasts in idiopathic pulmonary fibrosis. Marchand-Adam, S., Fabre, A., Mailleux, A.A., Marchal, J., Quesnel, C., Kataoka, H., Aubier, M., Dehoux, M., Soler, P., Crestani, B. Am. J. Respir. Crit. Care Med. (2006)
- Upregulation of HGF activator inhibitor type 1 but not type 2 along with regeneration of intestinal mucosa. Itoh, H., Kataoka, H., Tomita, M., Hamasuna, R., Nawa, Y., Kitamura, N., Koono, M. Am. J. Physiol. Gastrointest. Liver Physiol. (2000)
- Hepatocyte growth factor activator inhibitor types 1 and 2 are expressed by tubular epithelium in kidney and down-regulated in renal cell carcinoma. Yamauchi, M., Kataoka, H., Itoh, H., Seguchi, T., Hasui, Y., Osada, Y. J. Urol. (2004)
- Functional characterization of Kunitz domains in hepatocyte growth factor activator inhibitor type 2. Qin, L., Denda, K., Shimomura, T., Kawaguchi, T., Kitamura, N. FEBS Lett. (1998)
- Fluorescence correlation spectroscopy, a tool to investigate supramolecular dynamics: inclusion complexes of pyronines with cyclodextrin. Al-Soufi, W., Reija, B., Novo, M., Felekyan, S., Kühnemuth, R., Seidel, C.A. J. Am. Chem. Soc. (2005)
- Regulation of hepatocyte growth factor activator inhibitor 2 by hypoxia in breast cancer. Generali, D., Fox, S.B., Berruti, A., Moore, J.W., Brizzi, M.P., Patel, N., Allevi, G., Bonardi, S., Aguggini, S., Bersiga, A., Campo, L., Dogliotti, L., Bottini, A., Harris, A.L. Clin. Cancer Res. (2007)
- Possible role of region 152-156 in the structural duality of a peptide fragment from sheep prion protein. Megy, S., Bertho, G., Kozin, S.A., Debey, P., Hoa, G.H., Girault, J.P. Protein Sci. (2004)
- Identification and cloning of human placental bikunin, a novel serine protease inhibitor containing two Kunitz domains. Marlor, C.W., Delaria, K.A., Davis, G., Muller, D.K., Greve, J.M., Tamburini, P.P. J. Biol. Chem. (1997)
- Hepatocyte growth factor activator inhibitor 2/placental bikunin (HAI-2/PB) gene is frequently hypermethylated in human hepatocellular carcinoma. Fukai, K., Yokosuka, O., Chiba, T., Hirasawa, Y., Tada, M., Imazeki, F., Kataoka, H., Saisho, H. Cancer Res. (2003)